121 related articles for article (PubMed ID: 9067929)
1. Plasma mevalonate concentrations in uremic patients.
Scoppola A; De Paolis P; Menzinger G; Lala A; Di Giulio S
Kidney Int; 1997 Mar; 51(3):908-12. PubMed ID: 9067929
[TBL] [Abstract][Full Text] [Related]
2. Plasma angiopoietin-like protein 3 (ANGPTL3) concentration is associated with uremic dyslipidemia.
Shoji T; Hatsuda S; Tsuchikura S; Kimoto E; Kakiya R; Tahara H; Koyama H; Emoto M; Tabata T; Nishizawa Y
Atherosclerosis; 2009 Dec; 207(2):579-84. PubMed ID: 19540497
[TBL] [Abstract][Full Text] [Related]
3. High plasma adenine concentration in chronic renal failure and its relation to erythrocyte ATP.
Slominska EM; Szolkiewicz M; Smolenski RT; Rutkowski B; Swierczynski J
Nephron; 2002 Jun; 91(2):286-91. PubMed ID: 12053067
[TBL] [Abstract][Full Text] [Related]
4. Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin.
Sitter T; Schmidt M; Schneider S; Schiffl H
J Nephrol; 2002; 15(3):297-301. PubMed ID: 12113602
[TBL] [Abstract][Full Text] [Related]
5. Oxalic Acid as a uremic toxin.
Mydlík M; Derzsiová K
J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441
[TBL] [Abstract][Full Text] [Related]
6. Increased tissue factor pathway inhibitor levels in uremic patients on regular hemodialysis.
Kario K; Matsuo T; Yamada T; Matsuo M
Thromb Haemost; 1994 Mar; 71(3):275-9. PubMed ID: 8029788
[TBL] [Abstract][Full Text] [Related]
7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
8. Role of the kidneys in the metabolism of plasma mevalonate. Studies in humans and in rhesus monkeys.
McNamara DJ; Ahrens EH; Parker TS; Morrissey K
J Clin Invest; 1985 Jul; 76(1):31-9. PubMed ID: 4019781
[TBL] [Abstract][Full Text] [Related]
9. Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations.
McGregor DO; Dellow WJ; Lever M; George PM; Robson RA; Chambers ST
Kidney Int; 2001 Jun; 59(6):2267-72. PubMed ID: 11380830
[TBL] [Abstract][Full Text] [Related]
10. Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures.
Milionis HJ; Elisaf MS; Karabina SA; Bairaktari E; Tselepis AD; Siamopoulos KC
Kidney Int; 1999 Dec; 56(6):2276-85. PubMed ID: 10594806
[TBL] [Abstract][Full Text] [Related]
11. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis.
Attman PO; Alaupovic P
Nephron; 1991; 57(4):401-10. PubMed ID: 2046821
[TBL] [Abstract][Full Text] [Related]
12. Role of the kidneys in the metabolism of circulating mevalonate in humans.
Hughes-Fulford M; Feingold KR; Searle GL; Wu J; Siperstein MD; Schoenfeld PY; Kaysen G
J Clin Endocrinol Metab; 1986 Jun; 62(6):1227-31. PubMed ID: 3084536
[TBL] [Abstract][Full Text] [Related]
13. [The effect of cellulose diacetate dialysis membranes on lipids and lipoproteins in uremic patients].
Jakić M; Rupcić V; Stipanić S; Samardzija G; Bilandzija M; Zibar L; Mihaljević D; Milas J
Lijec Vjesn; 1997 Feb; 119(2):56-9. PubMed ID: 9297037
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency.
Lee DM; Knight-Gibson C; Samuelsson O; Attman PO; Wang CS; Alaupovic P
Kidney Int; 2002 Jan; 61(1):209-18. PubMed ID: 11786103
[TBL] [Abstract][Full Text] [Related]
15. Hemodialysis with regenerated cellulosic membranes does not reduce plasma selenium levels in chronic uremic patients.
Bonomini M; Manfrini V; Marini A; De Risio F; Niri L; Klinkmann H; Albertazzi A
Artif Organs; 1995 Jan; 19(1):81-5. PubMed ID: 7741645
[TBL] [Abstract][Full Text] [Related]
16. Possible role of mevalonate in the hypercholesterolemia seen in experimental chronic renal failure.
Subang MC; Stewart-Phillips JL; Pappu AS; Subang R; Gagnon RF
Nephron; 1995; 69(2):151-4. PubMed ID: 7723897
[TBL] [Abstract][Full Text] [Related]
17. Is aluminum toxicity responsible for uremic pruritus in chronic hemodialysis patients?
Friga V; Linos A; Linos DA
Nephron; 1997; 75(1):48-53. PubMed ID: 9031270
[TBL] [Abstract][Full Text] [Related]
18. Red blood cell calcium homeostasis in patients with end-stage renal disease.
Gafter U; Malachi T; Barak H; Djaldetti M; Levi J
J Lab Clin Med; 1989 Sep; 114(3):222-31. PubMed ID: 2527934
[TBL] [Abstract][Full Text] [Related]
19. Effects of chronic uremia, hemodialysis, and renal transplantation on plasma lipids and lipoproteins in man.
Bagdade J; Casaretto A; Albers J
J Lab Clin Med; 1976 Jan; 87(1):38-48. PubMed ID: 173766
[TBL] [Abstract][Full Text] [Related]
20. Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis.
Shoji T; Nishizawa Y; Kawagishi T; Tanaka M; Kawasaki K; Tabata T; Inoue T; Morii H
Atherosclerosis; 1997 Jun; 131(2):229-36. PubMed ID: 9199276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
